BRIEF published on 02/20/2025 at 07:35, 1 year 8 months ago Sensorion to Participate in March Investor Conferences Biotechnology Investor Conferences Sensorion Hearing Loss Therapies March 2025
PRESS RELEASE published on 02/20/2025 at 07:30, 1 year 8 months ago Inside Information / Other news releases Sensorion announces participation in investor conferences in March. CEO and CFO will attend Cowen and Leerink events to present company updates and meet investors Biotechnology CFO Investor Conferences CEO Sensorion
BRIEF published on 02/18/2025 at 07:35, 1 year 8 months ago Sensorion announces its participation in congresses in March 2025 Biotechnology Sensorion Hearing Therapies Medical Innovations Congress 2025
PRESS RELEASE published on 02/18/2025 at 07:30, 1 year 8 months ago Inside Information / Other news releases Sensorion announces participation in upcoming congresses in March to present on innovative biologics and manufacturing challenges for hearing loss disorders Sensorion Hearing Loss Biologics Congresses Manufacturing Challenges
BRIEF published on 02/12/2025 at 11:35, 1 year 8 months ago Sensorion to Participate in ARO 48th Annual Midwinter Meeting Sensorion Hearing Loss ARO Meeting GJB2-GT Therapy Biotech Conference
PRESS RELEASE published on 02/12/2025 at 11:30, 1 year 8 months ago Inside Information / Other news releases Sensorion announces participation in ARO 48th Annual Midwinter Meeting with focus on gene therapy for deafness. Details of presentations by Sensorion executives included Gene Therapy Sensorion ARO Meeting Deafness Sensorion Executives
BRIEF published on 12/27/2024 at 07:35, 1 year 9 months ago Sensorion Completes Enrollment for Audiogene Phase 1/2 Trial Gene Therapy Sensorion Hearing Loss SENS-501 Audiogene Trial
PRESS RELEASE published on 12/27/2024 at 07:30, 1 year 9 months ago Inside Information / Other news releases Sensorion completes enrollment of the first cohort in the Audiogene Phase 1/2 gene therapy clinical trial, targeting infants with hearing loss disorders Gene Therapy Clinical Trial Sensorion Hearing Loss Disorders Audiogene
BRIEF published on 12/18/2024 at 07:35, 1 year 10 months ago Sensorion Reports Positive Preliminary Results for SENS-501 Gene Therapy Clinical Trial SENS-501 Congenital Deafness Biotechnological Innovation
PRESS RELEASE published on 12/18/2024 at 07:30, 1 year 10 months ago Inside Information / Other news releases Sensorion reports positive safety data and behavioral changes in toddlers from the Audiogene Phase 1/2 Gene Therapy Clinical Trial. Plans KOL event in 2025 for further discussion Gene Therapy Clinical Trial Sensorion Hearing Loss Audiogene
Published on 10/20/2026 at 23:10, 2 hours 53 minutes ago Polaris Renewable Energy Awards Key Supply Contract and Issues Notice to Proceed on Punta Lima Battery Storage Investment
Published on 10/20/2026 at 22:00, 4 hours 3 minutes ago Eagle Plains Increases Saskatchewan Royalty Portfolio
Published on 10/20/2026 at 20:10, 5 hours 53 minutes ago Torq Resources Completes Extension of Credit Facility
Published on 10/20/2026 at 17:00, 9 hours 3 minutes ago GameSquare Announces The "Grand Theft Auto" Effect
Published on 10/20/2026 at 14:45, 11 hours 18 minutes ago NanoViricides' Revolutionary Broad-Spectrum Drug Candidate NV-387 Has Successfully Demonstrated Excellent Indications for Safety and Toxicology in a Juvenile Mouse Pups Animal Study, Paving the Way for Pediatric Use in Clinical Trials
Published on 10/20/2026 at 23:39, 2 hours 23 minutes ago EQS-Adhoc: NEXTDC Limited: M3 Melbourne Power Delay and Revised FY27 Guidance
Published on 10/20/2026 at 19:32, 6 hours 31 minutes ago Aroundtown significantly increases its share in German Residential Real Estate through GCP’s financial investment in LEG Immobilien SE
Published on 10/20/2026 at 19:31, 6 hours 32 minutes ago Aroundtown significantly increases its share in German Residential Real Estate through GCP’s financial investment in LEG Immobilien SE
Published on 10/20/2026 at 19:31, 6 hours 32 minutes ago Grand City Properties S.A. acquires 20% stake in LEG Immobilien SE to drive strong FFO growth
Published on 10/20/2026 at 19:29, 6 hours 34 minutes ago Aroundtown SA significantly increases its share in German Residential Real Estate through GCP’s financial investment in LEG Immobilien SE
Published on 10/20/2026 at 19:47, 6 hours 16 minutes ago Compagnie Chargeurs Invest becomes Belgrano and reaches a new milestone in the implementation of its public share buyback offer (OPRA)
Published on 10/20/2026 at 12:36, 13 hours 27 minutes ago CNP Assurances announces the signing of a binding agreement with Prudential Financial to acquire its insurance businesses in Brazil and Mexico
